A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer.
Han JY, Kim HY, Lim KY, Han JH, Lee YJ, Kwak MH, Kim HJ, Yun T, Kim HT, Lee JS.
Han JY, et al. Among authors: kim hy, kim hj, kim ht.
Lung Cancer. 2013 Feb;79(2):137-42. doi: 10.1016/j.lungcan.2012.09.019. Epub 2012 Nov 20.
Lung Cancer. 2013.
PMID: 23182663
Clinical Trial.